Induksi of Porphyromonas gingivalis Meningkatkan Proporsi Endotelin-1 pada Aorta Mencit yang Diinduksi Diet Aterogenik

Authors

  • Helmin Elyani Elyani Program Pendidikan Dokter, Universitas Islam Malang
  • Tinny Endang Hernowati Laboratorium Patologi Klinik Fakultas, Kedokteran Universitas Brawijaya
  • Sumarno Sumarno Laboratorium Biomedik, Fakultas Kedokteran Universitas Brawijaya

DOI:

https://doi.org/10.21776/ub.jkb.2009.025.02.7

Abstract

One of the risk factor of atherosclerosis is associated with activation of the inflammatory process in infection,as evidence by systemic elevations of molecules such as MCP-1,PAI-1 and ET-1. Recent evidence suggeststhat infectious agents, including those that cause periodontal disease, may also important role inatherosclerosis. The aim of this study was to determine if recurrent intravenous injections with P. gingivalis for14 weeks promotes endothelial smooth muscle ET-1 proportion in aortic mice. Twenty four weeks old mice(n=6 per group for each time point) were divided in two groups, there were normal diet and atherogenic diet,each of them were inoculated intravenously with live P. gingivalis (10 cell/50µl PBS) injections or vehicle (50µl PBS) once per week for 14 weeks. The Immunohistochemistry for aortic ET-1 proportion were performed.The result of RAK with 3 interaction and Tukey test using SPSS 14 for windows showed that at 14 weeks, theET-1 proportion in aortic endothelial cell was higher than in aortic smooth muscle cell.

Downloads

Download data is not yet available.

References

Rich S, McLaughlin VV. Endothelin receptor blockers in cardiovascular disease. . Circulation2003;108:2184-2190.

Gonzales D, Tzianabos AO, Genco CA, Gibson FC. Immunization with porphyromonas gingivalis c a p s u l a r p o l y s a c c h a r i d e p r e v e n t s Porphyromonas gingivalis elicited oral bone loss In murine model. . Infect Immun. 2003;71

Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal p a t h o g e n s i n a t e r o m a t o u s plaques.J.Periodontal. 2000; 71: 1554 -1560.

Kozarov E, Miyashita N, Burk J, Cerveny K, Brown TA, McArthur WP. Expession and immunoogenicity of hemaglutinin A from P gingivalis in an avirulent Salmonella entrica serovivar vaccine strain. Infect Immun. 2000; 68.

Clemens WJ, Zahlten B, Schmeck C, . et al Porphyromonas gingivalis strain-dependent activation of human endothelial cells. American Society for Microbiology. 2004; 84(7): 584-595.

Brodala N, Merricks EP, Bellinger DA, et al. P.gingivalis bacteriemia induces coronary and aortic atherosclerosis in normocholesterolemic And hypercholesterolemic pigs. Arteriosclerosis Thromb Vascular Disease. 2005; 25: 1.

Amano A, Nakagawa ON, Hamada N. . Variations of Porhyromonas gingivalis fimbriae in relation to microbial pathogenesis. J.Periodontal Research. 2004; 39.

Hajishengalis G, Sojar H, Genco RJ, DeNardin E. Intracellular signaling and cytokine induction upon interaction of Porphyromonas gingivalis fimbriae with pattern-recogniton receptor. Immunol Invest. 2004; 33.

Jian A, Batista EL, Serhan C, Stahl GL, Van Dyke TE. r p The role for periodontitis in the progression of lipid deposition in animal model. Infection and Immunity. 2003; 54:329-341,1997.

Ogawa T, Asai Y, Hashimoto M, Uchida H. Bacterial fimbriae activate human peripheral blood monocytes utilizing TLR2 ,CD14 and CD11a/CD 18 As cellular receptor. European J Immunol. 2001; 32.

Demmer RT, Desvarieux M. Periodontal infection and cardiovascular disease the heart of matter. Journal of American Dental Association. 2006; 37: 17S.

Cohen N, Moriset J, Emilie D. Induction of tolerance by Porphyromonas gingivalis on APCs: a mechanism implicated in periodontal infection. J Dental Res. 2004; 83.

Zhou Q, Desta T, Fenton M, Graves DT, Amar S. Cytokine profiling of machrophge exposed to Porphyromonas gingivalis its, LPS or its FimA protein.Infect Immun.2005;73.

Oda T, Yoshie H, Yamazaki K. Porphyromonas gingivalis antigen preferentially stimulates T Cell to Express IL17 but not receptor activator of NFKB ligand in vitro. Oral Microbiol Immunol. 2003; 18.

Kollenbrader PE,London J. Adhere today, here, tomorrow:oral bacterial adherence. J.Bacteriol. 1993; 175.

DeCarlo AA, HuangY, Coller CA, Langley DB, Karzt J. Feasibility of an HA2 domain based periodontitis vaccine. Infection Immun. 2003; 71.

Okahashi N, Inaba H, Nakagawa I , Yamamura T, Kuboniwa M, Nakayama K. Porphyromonas gingivalis induces receptor activator of NFKB ligand in expression in osteoblast through the activator of protein 1 pathway. Infect Immun. 2004; 72.

Nakagawa T, Saito A, Hosaka Y, Ishikara K. Gingipains as candidate antigens for P. gingivalis vaccine. Keio J Med. 2003; 52.

N a k a y a m a K . M o l e c u l a r g e n e t i c s o f Porphyromonas gingivalis gingipains and othe virulence factors. Current Protein Pept Sci. 2003; 4.

Yilmaz O, Young PA, Lamont RJ, Kenny GE. Gingival epithelial cell signaling and cytoskeletal responses to Porphyromonas gingivalis invasion. Microbiology. 2003; (149) :2417.

Thelade E, Hill MJ, Marsh PD . Factors controlling the microflora of healthy mouth Human Microbial Ecology. CRC Press Inc Boca Raton Fla; 1990.

Lepine G, Ellen RP, Progulske-Fox A. construction and preliminary characterisation of three hemaglutinin mutans of P gingivalis. Oral Microbiol Immunol.1996;11.

Duncan L, Yoshioka M, Chandad F, Grenier D. Loss of LPS receptor CD14 from surface of human macrophage -like cells mediated by Porphyromonas gingivalis outer membrane vesicles. Microbiol. Pathog. 2004; 36.

Hernowati. Pengaruh OMP P. gingivalis terhadap PAI-1,MCP-1 dan ET-1 pada kultur HUVEC'S . 2006.

Rozenweig A. Circulating endothelial progenitor cell as biomarkers. New England Journal. 2005;353(10):1055-1057.

L u d e w i g I B , K r e b s P, S c a n d e l l a E . Immunopathogenesis of atherosclerosis. Journal of Leukocyte Biology. 2002; 76: 300-306.

Dhaun N, Goddard J, Webb DJ. The Endothelin system and its antagonism in chronic kidney disease -. J Am Soc Nephrol. 2006; 17: 943 955.

Luscher TF, Barton M. Endothelins and endothelin receptor antagonists : therapeutic c o n s i d e r a t i o n s f o r a n o v e l c l a s s o f cardiovascular drugs. Circulation. 2000; 102; 2434-2440.

Li L, Messas E, Batista Jr EL, Levine RA, Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E deficient murine model. Circulation. 2002; 105: 861-867.

Downloads

Published

2013-03-15

Issue

Vol. 25 No. 2 (2009)

Section

Research Article

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Most read articles by the same author(s)

1 2 > >>